COVID-19: consider cytokine storm syndromes and immunosuppression
As of March 12, 2020, coronavirus disease 2019 (COVID-19) has been con firmed in 125 048
people worldwide, carrying a mortality of approximately 3· 7%, 1 compared with a mortality …
people worldwide, carrying a mortality of approximately 3· 7%, 1 compared with a mortality …
Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system
PK Mehta, KK Griendling - American Journal of Physiology …, 2007 - journals.physiology.org
The renin-angiotensin system is a central component of the physiological and pathological
responses of cardiovascular system. Its primary effector hormone, angiotensin II (ANG II), not …
responses of cardiovascular system. Its primary effector hormone, angiotensin II (ANG II), not …
Silencing the cytokine storm: the use of intravenous anakinra in haemophagocytic lymphohistiocytosis or macrophage activation syndrome
The term cytokine storm syndromes describes conditions characterised by a life-threatening,
fulminant hypercytokinaemia with high mortality. Cytokine storm syndromes can be genetic …
fulminant hypercytokinaemia with high mortality. Cytokine storm syndromes can be genetic …
COVID-19-associated hyperinflammation and escalation of patient care: a retrospective longitudinal cohort study
…, B Goulden, T Liddle, E Khan, P Mehta… - The Lancet …, 2020 - thelancet.com
Background A subset of patients with severe COVID-19 develop a hyperinflammatory
syndrome, which might contribute to morbidity and mortality. This study explores a specific …
syndrome, which might contribute to morbidity and mortality. This study explores a specific …
Ischemia and no obstructive coronary artery disease (INOCA) developing evidence-based therapies and research agenda for the next decade
The Cardiovascular Disease in Women Committee of the American College of Cardiology,
in conjunction with interested parties (from the National Heart, Lung, and Blood Institute, …
in conjunction with interested parties (from the National Heart, Lung, and Blood Institute, …
Therapeutic blockade of granulocyte macrophage colony-stimulating factor in COVID-19-associated hyperinflammation: challenges and opportunities
The COVID-19 pandemic is a global public health crisis, with considerable mortality and
morbidity exerting pressure on health-care resources, including critical care. An excessive host …
morbidity exerting pressure on health-care resources, including critical care. An excessive host …
The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings
Preliminary clinical data indicate that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
infection is associated with neurological and neuropsychiatric illness. Responding …
infection is associated with neurological and neuropsychiatric illness. Responding …
Ranolazine improves angina in women with evidence of myocardial ischemia but no obstructive coronary artery disease
PK Mehta, P Goykhman, LEJ Thomson… - JACC: Cardiovascular …, 2011 - jacc.org
Objectives : We conducted a pilot study for a large definitive clinical trial evaluating the impact
of ranolazine in women with angina, evidence of myocardial ischemia, and no obstructive …
of ranolazine in women with angina, evidence of myocardial ischemia, and no obstructive …
Local and systemic responses to SARS-CoV-2 infection in children and adults
It is not fully understood why COVID-19 is typically milder in children 1 , 2 – 3 . Here, to examine
the differences between children and adults in their response to SARS-CoV-2 infection, …
the differences between children and adults in their response to SARS-CoV-2 infection, …
Cerebral venous sinus thrombosis and thrombocytopenia after COVID-19 vaccination–A report of two UK cases
PR Mehta, SA Mangion, M Benger, BR Stanton… - Brain, behavior, and …, 2021 - Elsevier
Recent reports have highlighted rare, and sometimes fatal, cases of cerebral venous sinus
thrombosis (CVST) and thrombocytopenia following the Vaxzevria vaccine. An underlying …
thrombosis (CVST) and thrombocytopenia following the Vaxzevria vaccine. An underlying …
